Wegovy Approved in U.S. to Reduce Risk of Heart Attacks, Strokes
Wall Street Journal
Novo Nordisk can now begin promoting that its popular anti-obesity drug can also boost heart health–a claim that could increase pressure on reluctant employers and insurers to pay for the drug.
https://www.wsj.com/articles/novo-nordisk-can-now-say-wegovy-improves-heart-health-2d8ee6f4